Cargando…

The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery

Cardiac output (CO) is expected to affect elimination and distribution of highly extracted and perfusion rate-limited drugs. This work was undertaken to quantify the effect of CO measured by the pulse pressure method on pharmacokinetics and pharmacodynamics of propofol and fentanyl administrated dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Bienert, Agnieszka, Sobczyński, Paweł, Młodawska, Katarzyna, Hartmann-Sobczyńska, Roma, Grześkowiak, Edmund, Wiczling, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652808/
https://www.ncbi.nlm.nih.gov/pubmed/32840723
http://dx.doi.org/10.1007/s10928-020-09712-1
_version_ 1783607769294700544
author Bienert, Agnieszka
Sobczyński, Paweł
Młodawska, Katarzyna
Hartmann-Sobczyńska, Roma
Grześkowiak, Edmund
Wiczling, Paweł
author_facet Bienert, Agnieszka
Sobczyński, Paweł
Młodawska, Katarzyna
Hartmann-Sobczyńska, Roma
Grześkowiak, Edmund
Wiczling, Paweł
author_sort Bienert, Agnieszka
collection PubMed
description Cardiac output (CO) is expected to affect elimination and distribution of highly extracted and perfusion rate-limited drugs. This work was undertaken to quantify the effect of CO measured by the pulse pressure method on pharmacokinetics and pharmacodynamics of propofol and fentanyl administrated during total intravenous anesthesia (TIVA). The data were obtained from 22 ASA III patients undergoing abdominal aortic surgery. Propofol was administered via target-controlled infusion system (Diprifusor) and fentanyl was administered at a dose of 2–3 µg/kg each time analgesia appeared to be inadequate. Hemodynamic measurements as well as bispectral index were monitored and recorded throughout the surgery. Data analysis was performed by using a non-linear mixed-effect population modeling (NONMEM 7.4 software). Three compartment models that incorporated blood flows as parameters were used to describe propofol and fentanyl pharmacokinetics. The delay of the anesthetic effect, with respect to plasma concentrations, was described using a biophase (effect) compartment. The bispectral index was linked to the propofol and fentanyl effect site concentrations through a synergistic E(max) model. An empirical linear model was used to describe CO changes observed during the surgery. Cardiac output was identified as an important predictor of propofol and fentanyl pharmacokinetics. Consequently, it affected the depth of anesthesia and the recovery time after propofol-fentanyl TIVA infusion cessation. The model predicted (not observed) CO values correlated best with measured responses. Patients‘ age was identified as a covariate affecting the rate of CO changes during the anesthesia leading to age-related difference in individual patient’s responses to both drugs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10928-020-09712-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7652808
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-76528082020-11-12 The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery Bienert, Agnieszka Sobczyński, Paweł Młodawska, Katarzyna Hartmann-Sobczyńska, Roma Grześkowiak, Edmund Wiczling, Paweł J Pharmacokinet Pharmacodyn Original Paper Cardiac output (CO) is expected to affect elimination and distribution of highly extracted and perfusion rate-limited drugs. This work was undertaken to quantify the effect of CO measured by the pulse pressure method on pharmacokinetics and pharmacodynamics of propofol and fentanyl administrated during total intravenous anesthesia (TIVA). The data were obtained from 22 ASA III patients undergoing abdominal aortic surgery. Propofol was administered via target-controlled infusion system (Diprifusor) and fentanyl was administered at a dose of 2–3 µg/kg each time analgesia appeared to be inadequate. Hemodynamic measurements as well as bispectral index were monitored and recorded throughout the surgery. Data analysis was performed by using a non-linear mixed-effect population modeling (NONMEM 7.4 software). Three compartment models that incorporated blood flows as parameters were used to describe propofol and fentanyl pharmacokinetics. The delay of the anesthetic effect, with respect to plasma concentrations, was described using a biophase (effect) compartment. The bispectral index was linked to the propofol and fentanyl effect site concentrations through a synergistic E(max) model. An empirical linear model was used to describe CO changes observed during the surgery. Cardiac output was identified as an important predictor of propofol and fentanyl pharmacokinetics. Consequently, it affected the depth of anesthesia and the recovery time after propofol-fentanyl TIVA infusion cessation. The model predicted (not observed) CO values correlated best with measured responses. Patients‘ age was identified as a covariate affecting the rate of CO changes during the anesthesia leading to age-related difference in individual patient’s responses to both drugs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10928-020-09712-1) contains supplementary material, which is available to authorized users. Springer US 2020-08-25 2020 /pmc/articles/PMC7652808/ /pubmed/32840723 http://dx.doi.org/10.1007/s10928-020-09712-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Bienert, Agnieszka
Sobczyński, Paweł
Młodawska, Katarzyna
Hartmann-Sobczyńska, Roma
Grześkowiak, Edmund
Wiczling, Paweł
The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery
title The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery
title_full The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery
title_fullStr The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery
title_full_unstemmed The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery
title_short The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery
title_sort influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652808/
https://www.ncbi.nlm.nih.gov/pubmed/32840723
http://dx.doi.org/10.1007/s10928-020-09712-1
work_keys_str_mv AT bienertagnieszka theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT sobczynskipaweł theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT młodawskakatarzyna theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT hartmannsobczynskaroma theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT grzeskowiakedmund theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT wiczlingpaweł theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT bienertagnieszka influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT sobczynskipaweł influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT młodawskakatarzyna influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT hartmannsobczynskaroma influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT grzeskowiakedmund influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery
AT wiczlingpaweł influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery